When Peptide Injections Turned Dangerous: A Nevada Regulatory Reckoning
In July 2023, a scene from a Las Vegas anti-aging conference escalated into a medical emergency. Two women received peptide injections at a booth during the Revolution Against Aging and Death (RAAD) Festival and were later rushed to ambulances, critically ill and requiring intubation to breathe. They have since recovered. This incident has triggered a rare regulatory response in Nevada, shining a light on the murky, largely unregulated world of peptide therapies marketed for anti-aging and regenerative health.
The Fines and the Accused
Last month, the Nevada State Board of Pharmacy levied financial penalties against four entities and individuals connected to the treatments. The board fined Dr. Kent Holtorf, a California-licensed physician whose practice is based in El Segundo, $10,000 for practicing medicine in Nevada without a license. Han Bao Nguyen, a pharmacist licensed in California who works at Holtorf’s practice, also received a $10,000 fine for the same violation and for allegedly mixing and administering the peptide serums.
A third individual, Michael McNeal—who describes himself as an “integrative health coach” and serves as director of education for a Holtorf-founded company—was fined $5,000. The board stated he does not appear to hold any healthcare license but was accused of prescribing or recommending a peptide cocktail to one of the women.
The most significant fine, another $10,000, was imposed on Forgotten Formula, a Texas-based private membership association (PMA). The board accused the group of “unlicensed wholesaling of drugs” for mailing the peptides to the Las Vegas casino resort hosting RAADFest, with the package marked “to the attention of Dr. Kent Holtorf.”
The Event and the Unanswered Questions
The injections occurred at a booth operated by Dr. Holtorf during RAADFest, an event organized by an Arizona-based group that promotes pathways to an “unlimited lifespan.” Peptides—short chains of amino acids—have surged in popularity within wellness circles for purported anti-aging and chronic disease benefits, though their use for these purposes is largely experimental and not approved by the Food and Drug Administration (FDA).
The Nevada pharmacy board’s investigation, however, hit a critical wall. Investigators were unable to obtain the actual peptide serums used at the event, preventing any laboratory testing for contamination or precise composition. “We were not able to obtain the product, although attempts were made,” said David Wuest, the board’s executive secretary. Consequently, the board could not determine a definitive cause for the women’s sudden, severe illness—whether from a contaminated product, an adverse reaction to the peptides themselves, or other factors.
The Gray Market of Peptides
The case exposes a booming, loosely regulated gray market. While the FDA has approved many peptide-based drugs for serious conditions like diabetes and cancer, their use for anti-aging is not sanctioned. Compounding pharmacies can legally prepare some peptides, but the FDA has listed 19 popular anti-aging peptides as posing “significant safety risks,” prohibiting their dispensing by compounding pharmacies. This has driven demand to suppliers operating outside these rules, both domestically and internationally.
The Nevada board’s citation noted that the injections administered at the festival included at least one peptide on the FDA’s risk list. This regulatory landscape may be shifting; Health and Human Services Secretary Robert F. Kennedy Jr., a noted peptide proponent, has said the FDA plans to reclassify 14 of these peptides, which could eventually allow compounded versions. For now, the incident underscores the potential dangers of products from unverified sources.
Legal Shield or Regulatory Loophole?
Forgotten Formula’s trustee, Michael Blake Fiveash, contested the board’s authority. He argued that as a private membership association, its transactions with contracted members are protected by the First and 14th Amendments and occur “outside the scope” of state commercial regulations. In a letter to ProPublica, Fiveash stated the association “did not supply materials for public commercial use or public distribution” at RAADFest. He claimed Dr. Holtorf was acting under his separate, public medical practice, not as an association member, and that the ill women were not association members.
Fiveash did not directly answer whether the association mailed the peptides to Holtorf. He also shared member testimonials—including from children and adults with serious illnesses—attributing health improvements to the association’s products. He challenged the narrative linking the peptides to the women’s illnesses, calling it “speculation masquerading as reporting” without comprehensive toxicology and full medical histories.
Laura Tucker, the board’s lawyer, acknowledged this is the board’s first encounter with a PMA making such constitutional claims but maintained that mailing prescription drugs into Nevada without a state license violates state law. Any party can appeal their citation to the board. “Of course anyone is free to make any sort of legal argument they would like to try to make in front of the board,” she said.
Broader Implications and Ongoing Oversight
The Nevada Pharmacy Board has formally notified California’s medical and pharmacy boards—which license Dr. Holtorf and Mr. Nguyen—of its findings, potentially opening the door for additional disciplinary action there. The board has also alerted the FDA. Dr. Holtorf did not respond to requests for comment for this article. In a July statement to ProPublica after the incident, he said he did not believe the peptides caused the illnesses, citing an analysis from an artificial intelligence app, which he did not share. He apologized and said he was “reassessing everything we are doing.”
This case serves as a stark example of the collision between the high-demand wellness industry and existing regulatory frameworks. It highlights the risks patients may face when seeking cutting-edge therapies from providers operating across state lines and through private associations claiming exemptions. While the immediate fines address Nevada-specific licensing violations, the unresolved medical mystery and the legal arguments from Forgotten Formula suggest this regulatory battle is far from over, with implications that extend far beyond the Las Vegas convention floor.
